Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K Potkul

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Gynecologic Oncology|May 1, 1997
Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cellsD Street, A M Kaufmann, A Vaughan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Cervical cancer cells induce apoptosis of cytotoxic T lymphocytesD N Contreras, P H Krammer, R K Potkul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancerK Kono, M E Ressing, R M Brandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacyL A Small, D M Da Silva, K E de Visser, et al.
Gynecologic Oncology|March 1, 1991
Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestineJ F Barter, D Marlow, R K Kamath, et al.
Cytokines and Molecular Therapy|September 1, 1996
Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimensP Lichter, K Fischer, S Joos, et al.
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impairedJ D Nieland, K Loviscek, K Kono, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Gynecologic Oncology|May 1, 1997
Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cellsD Street, A M Kaufmann, A Vaughan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Cervical cancer cells induce apoptosis of cytotoxic T lymphocytesD N Contreras, P H Krammer, R K Potkul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancerK Kono, M E Ressing, R M Brandt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
A murine model for the effects of pelvic radiation and cisplatin chemotherapy on human papillomavirus vaccine efficacyL A Small, D M Da Silva, K E de Visser, et al.
Gynecologic Oncology|March 1, 1991
Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestineJ F Barter, D Marlow, R K Kamath, et al.
Cytokines and Molecular Therapy|September 1, 1996
Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimensP Lichter, K Fischer, S Joos, et al.
Gynecologic Oncology|September 10, 1999
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group studyE A Poplin, P Y Liu, J E Delmore, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR zeta expression but are functionally impairedJ D Nieland, K Loviscek, K Kono, et al.
Pageof 3